14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 60 days ( 0 % )
Last Price $0.435 0 %
High/ Low $0.435 - $0.435 0%
Chg 7 Days N/A $0.435 $0.435
Chg 30 Days N/A $0.435 $0.435
Chg 12 mos -27.20 % $0.597 $0.435
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -2.93 % Width: 302.78 %
Pred. range - 3 mos $0.435 - $0.435 0 % - 0 %
Pred. range - 12 mos N/A - $6.33 -100.00 % - 1,354.60 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Sep 28, 2023 - 80 days
Long MA avg 12 mos Sell Sep 20, 2023 - 86 days
Short/Long MA avg 12 mos Sell Aug 10, 2023 - 114 days
Pivot Short Buy Oct 24, 2023 - 62 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Biocept

Biocept Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The compa... BIOC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT